| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000024749 |
| Receipt No. | R000028472 |
| Official scientific title of the study | Exploratory research of the role and regulation of alveolar nitric oxide on physical inactivity in COPD |
| Date of disclosure of the study information | 2016/11/08 |
| Last modified on | 2016/11/08 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Exploratory research of the role and regulation of alveolar nitric oxide on physical inactivity in COPD | |
| Title of the study (Brief title) | Research of alveolar nitric oxide on physical inactivity in COPD | |
| Region |
|
|
| Condition | |||
| Condition | COPD | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To elucidate whether there is a relation between physical inactivity and alveolar nitric oxide, the role and related inlammatory molecules in COPD |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Relationship of physical inactivity and exhaled NO in COPD by a cross-sectional manner |
| Key secondary outcomes | The time course of the development on physical inactivity and exhaled NO in COPD |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients will be eligible for inclusion in this study if all of the following criteria are met:
1. Patients are stable for at least 4 weeks prior to this study. 2. Patients received an explanation of the study protocol and gave written informed consent. 3. Patients are regardless of inpatients or outpatients. Subjects will be eligible for inclusion in this study if all of the following criteria are met: 1. Subjects received an explanation of the study protocol and gave written informed consent. |
|||
| Key exclusion criteria | Patients will be excluded in this study if any of the following criteria exist.
1. Patients have had an exacerbation for 4 weeks prior to this study and have been changed therapeutic strategy in stable status 2. Patients are with poor adherence to therapy 3. Patients have the factors that affect walking and physical activity, such as trauma or lower limb paralysis. 4. Patients are inadequate to include in this study.(Ex: complicaton of malignant tumor) Subjects will be excluded in this study if any of the following criteria. 1. Subjects have the factors that affect walking and physical activity, such as trauma or lower limb paralysis. 2. Subjects are inadequate to include in this study.(Ex: complication of malignant tumor) |
|||
| Target sample size | 120 | |||
| Research contact person | |
| Name of lead principal investigator | Tsunahiko Hirano |
| Organization | Yamaguchi University Hospital |
| Division name | Respiratory Medicine and Infectious Disease |
| Address | 1-1-1 Minami-kogushi, Ube, 755-8505, Japan |
| TEL | 0836-85-3123 |
| tsuna@yamaguchi-u.ac.jp | |
| Public contact | |
| Name of contact person | Tsunahiko Hirano |
| Organization | Yamaguchi University Hospital |
| Division name | Respiratory Medicine and Infectious Disease |
| Address | 1-1-1 Minami-kogushi, Ube, 755-8505, Japan |
| TEL | 0836-85-3123 |
| Homepage URL | |
| tsuna@yamaguchi-u.ac.jp | |
| Sponsor | |
| Institute | Yamaguchi University Hospital
Respiratory Medicine and Infectious Disease |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding
|
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 山口大学医学部附属病院(山口県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Case-referent study
Recruit subjects by posters |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028472 |